E

Exact Sciences Corp
D

EXAS

59.370
USD
3.29
(5.87%)
Market Closed
Volume
80,776
EPS
-1
Div Yield
-
P/E
-51
Market Cap
10,987,979,515
OverviewSignalsIdeasNews
Related Instruments
    A
    ALGN
    -2.420
    (-1.13%)
    211.130 USD
    ILMN
    ILMN
    2.030
    (1.52%)
    135.930 USD
    ISRG
    ISRG
    1.09
    (0.21%)
    524.91 USD
    N
    NVCR
    0.430
    (1.41%)
    30.830 USD
    P
    PODD
    9.70
    (3.78%)
    266.41 USD
    R
    RGEN
    -2.045
    (-1.39%)
    144.570 USD
    T
    TDOC
    0.48000
    (5.35%)
    9.45000 USD
    T
    TECH
    1.850
    (2.59%)
    73.230 USD
    V
    VEEV
    4.360
    (1.98%)
    224.170 USD
    More
News

Title: Exact Sciences Corp

Sector: Healthcare
Industry: Diagnostics & Research
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.